JP2008510685A5 - - Google Patents

Download PDF

Info

Publication number
JP2008510685A5
JP2008510685A5 JP2007526129A JP2007526129A JP2008510685A5 JP 2008510685 A5 JP2008510685 A5 JP 2008510685A5 JP 2007526129 A JP2007526129 A JP 2007526129A JP 2007526129 A JP2007526129 A JP 2007526129A JP 2008510685 A5 JP2008510685 A5 JP 2008510685A5
Authority
JP
Japan
Prior art keywords
blood cancer
picornavirus
treating
subject
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007526129A
Other languages
English (en)
Japanese (ja)
Other versions
JP5054522B2 (ja
JP2008510685A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2005/001257 external-priority patent/WO2006017914A1/en
Publication of JP2008510685A publication Critical patent/JP2008510685A/ja
Publication of JP2008510685A5 publication Critical patent/JP2008510685A5/ja
Application granted granted Critical
Publication of JP5054522B2 publication Critical patent/JP5054522B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007526129A 2004-08-20 2005-08-22 血液ガンを治療するための方法および組成物 Expired - Fee Related JP5054522B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2004904766 2004-08-20
AU2004904766A AU2004904766A0 (en) 2004-08-20 Treatment for hematologic cancers
AU2005901879 2005-04-14
AU2005901879A AU2005901879A0 (en) 2005-04-14 Methods and compositions for treatment of hematologic cancers
PCT/AU2005/001257 WO2006017914A1 (en) 2004-08-20 2005-08-22 Methods and compositions for treatment of hematologic cancers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012055445A Division JP2012144549A (ja) 2004-08-20 2012-03-13 血液ガンを治療するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2008510685A JP2008510685A (ja) 2008-04-10
JP2008510685A5 true JP2008510685A5 (https=) 2008-09-04
JP5054522B2 JP5054522B2 (ja) 2012-10-24

Family

ID=35907185

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007526129A Expired - Fee Related JP5054522B2 (ja) 2004-08-20 2005-08-22 血液ガンを治療するための方法および組成物
JP2012055445A Pending JP2012144549A (ja) 2004-08-20 2012-03-13 血液ガンを治療するための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012055445A Pending JP2012144549A (ja) 2004-08-20 2012-03-13 血液ガンを治療するための方法および組成物

Country Status (6)

Country Link
US (3) US8236298B2 (https=)
EP (1) EP1793851B1 (https=)
JP (2) JP5054522B2 (https=)
KR (1) KR101295733B1 (https=)
CA (1) CA2577692C (https=)
WO (1) WO2006017914A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2577692C (en) * 2004-08-20 2014-05-06 Viralytics Limited Methods and compositions for treatment of hematologic cancers
EP2125032A4 (en) 2007-02-20 2011-02-23 Mayo Foundation CANCER TREATMENT WITH VIRAL NUCLEIC ACID
WO2009139921A2 (en) * 2008-05-16 2009-11-19 Genelux Corporation Microorganisms for preventing and treating neoplasms accompanying cellular therapy
CA2915397A1 (en) * 2013-06-17 2014-12-24 Viralytics Limited Methods for the treatment of bladder cancer
WO2015127501A1 (en) * 2014-02-27 2015-09-03 Viralytics Limited Combination method for treatment of cancer
EP3064207B1 (en) * 2015-03-04 2017-12-20 Scandion Oncology A/S 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives for use as BCRP inhibitors in therapeutic treatments
RU2749050C2 (ru) 2016-01-27 2021-06-03 Онкорус, Инк. Онколитические вирусные векторы и их применение
US20190202886A1 (en) * 2016-05-11 2019-07-04 Ohio State Innovation Foundation ONCOLYTIC VIRUSES COMPRISING esRAGE AND METHODS OF TREATING CANCER
RU2021127872A (ru) 2016-06-30 2021-11-09 Онкорус, Инк. Доставка терапевтических полипептидов посредством псевдотипированных онколитических вирусов
AU2018306455A1 (en) 2017-07-26 2020-02-27 Virogin Biotech Canada Ltd Oncolytic viral vectors and uses thereof
US11865081B2 (en) 2017-12-29 2024-01-09 Virogin Biotech Canada Ltd. Oncolytic viral delivery of therapeutic polypeptides
CA3207359A1 (en) 2021-02-05 2022-08-11 Cecile Chartier-Courtaud Adjuvant therapy for cancer
JP2023085151A (ja) * 2021-12-08 2023-06-20 株式会社八神製作所 体外ホウ素中性子反応を用いた幹細胞の分取方法
EP4724111A2 (en) * 2023-06-08 2026-04-15 The Trustees Of Columbia University In The City Of New York Intracellular delivery of therapeutic cargos and viral rnas by engineered salmonella

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ517573A (en) 1999-09-17 2004-02-27 Pro Virus Inc Sequences of the oncolytic virus strain vesicular stromatitis virus (VSV)
AUPQ425699A0 (en) * 1999-11-25 1999-12-23 University Of Newcastle Research Associates Limited, The A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
AU2004202292B2 (en) 1999-11-25 2007-06-14 Viralytics Limited Method of Treating a Malignancy in a Subject
HK1052950B (en) 2000-06-26 2005-06-24 Wellstat Biologics Corporation Purging of cells using viruses
EP1385466B1 (en) 2001-05-11 2011-03-09 Wellstat Biologics Corporation Oncolytic virus therapy
AU2002953436A0 (en) 2002-12-18 2003-01-09 The University Of Newcastle Research Associates Limited A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
AU2005221725B2 (en) * 2004-03-11 2010-06-24 Viralytics Limited Modified oncolytic viruses
TWI234446B (en) * 2004-04-06 2005-06-21 Wilmart Co Ltd Adjustable body-fitted sleeping bag
CA2577692C (en) * 2004-08-20 2014-05-06 Viralytics Limited Methods and compositions for treatment of hematologic cancers

Similar Documents

Publication Publication Date Title
JP2008510685A5 (https=)
CL2007003250A1 (es) Compuestos derivados de isoquinolina, inhibidores del virus de hepatitis c; composicion farmaceutica; y uso para el tratamiento de una infeccion por vhc.
NZ594105A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
WO2009029622A3 (en) Antiviral drugs for treatment of arenavirus infection
BR112012011100A2 (pt) compostos inibidores do vírus da hepatite, composição e uso dos mesmos
CL2007002284A1 (es) Compuestos derivados de tetrazolilos macrociclicos; proceso de preparacion; composicion farmaceutica; y uso para tratar una infeccion viral de hepatitis c.
NO20090453L (no) Hepatitt C Virusinhibitorer
CL2008000751A1 (es) Compuestos derivados de cicloprop[d]indolo[2,1-a][2]benzacepina sustituidos con heterociclos; composicion farmaceutica; y uso en el tratamiento de infeccion por hepatitis c.
BRPI1013394A2 (pt) "composto, composição farmacêutica, uso do composto, e, método para tratar um paciente infectado com virus da hepatite c."
BRPI0511834A (pt) métodos por tratar hepatite c
WO2008021936A3 (en) Hepatitis c virus inhibitors
EP2124921A4 (en) SULFONYL SEMI-CARBAZIDES, CARBONYL SEMI-CARBAZIDS, SEMI-CARBAZIDS AND UREA, PHARMACEUTICAL COMPOSITIONS THEREOF, AND PROCESS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING ARENAVIRUS-ASSOCIATED INFECTIONS
CL2009002206A1 (es) Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
WO2008100867A3 (en) Novel inhibitors hepatitis c virus replication
WO2008045238A3 (en) Stabilized therapeutic small helical antiviral peptides
JP2009511595A5 (https=)
IL207468A (en) HCV inhibitors and their use in the preparation of medicines for the treatment of HCV infections
EA201500871A8 (ru) Ингибиторы репликации вирусов гриппа
CY1112999T1 (el) Αναστολεις ιου ηπατιτιδας c
JP2010529118A5 (https=)
WO2007041487A3 (en) Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family
WO2007125501A3 (en) Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness
WO2007084435A8 (en) Methods for treating hepatitis c
WO2007014619A8 (en) Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
WO2008069917A3 (en) Novel cyclic peptides